Physician profile
Ajit Shrestha
NPI 1790914273
$2,728.40
in general payments reported to CMS, 2019-2025
13 companies · $270 in 2025
The $270 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $672 · 2020: $60.64 · 2021: $374 · 2022: $327 · 2023: $624 · 2024: $401 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,294.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,583.43 | 2019-2025 | Eterna, Proclaim, Axium |
| Medtronic, INC. | $248.40 | 2022-2024 | Intellis Adaptivestim |
| Collegium Pharmaceutical, INC. | $167.24 | 2023-2024 | Belbuca, Xtampza |
| Relievant Medsystems, INC. | $157.72 | 2023 | Intracept |
| Curonix LLC | $141.76 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biodelivery Sciences International, INC. | $135.92 | 2021 | |
| Averitas Pharma INC. | $92.41 | 2023-2024 | Qutenza |
| Si-Bone, INC. | $54.11 | 2022 | |
| Spr Therapeutics, INC | $52.08 | 2019 | |
| Novartis Pharmaceuticals Corporation | $49.00 | 2019 | |
| Pfizer INC. | $16.93 | 2023 | |
| Shionogi INC | $14.84 | 2019 | |
| Daiichi Sankyo INC. | $14.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajit Shrestha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.